Pfizer just penned a $6 billion licensing deal with China's 3SBio to develop and commercialize a cancer drug, SSGJ-707. The ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics ... If those results are positive the partners have said they could file for approval in the ...

Bristol Myers Squibb (BMY) and MPLX present compelling value picks, offering high-income potential and attractive valuations ...

Pfizer and BioNTech said their alliance aims to develop an "improved" vaccine for shingles, and marks their third partnership in ... easily scalable to support global access," he added.

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for ...

Metro Loft and David Werner’s secured $720 million of construction financing to execute New York City’s largest office-resi ...

A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...

The University of California, Davis has announced two new strategic partnerships designed to strengthen its position as a ...

PETAH-TIKVA, Israel, May 14, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer eCommerce enablement, and Shopify, a leading commerce technology ...

US House Panel Seeks Information From Pfizer Over Alleged COVID Vaccine Delay ... the company's former global head of vaccine research, who helped oversee development of the COVID shot during ...